Business● Low15m ago · Nov 13, 2026, 4:34 PM
Xenetic Biosciences GAAP EPS of -$0.72, revenue of $0.7M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Xenetic Biosciences reported GAAP Earnings Per Share of -$0.72 and revenues of $0.7 million. These figures indicate the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business13m agoEgypt to legalize the status of "Dahhabah" by launching a new companyAsharq Al-Awsat [ar] · Saudi ArabiaBusiness15m agoSame metric, still a mess: The geoeconomics of youth unemployment in ChinaAtlantic CouncilBusiness15m agoAngola aims to acquire 10% stake in De Beers under Anglo American's proposed exitSeeking Alpha TechBusiness16m agoKoil Energy Solutions GAAP EPS of $0.02, revenue of $10.3MSeeking Alpha Tech